RYTM

113.0603.20%
LM

Lee M. Kaplan

Chairman of Scientific Advisory Board

Dr. Lee M. Kaplan, M.D., Ph.D. serves as Member of Clinical & Scientific Advisory Board of Skye Bioscience, Inc. (formerly known as Emerald Bioscience Inc.) since July 2024. Dr. Kaplan serves as Member of Clinical Advisory Board at Intellihealth, Inc. and Member of Obesity Scientific Advisory Board at Altimmune Inc. since 2023. He is an Associate Professor of Medicine at Harvard Medical School and Gastroenterologist of Massachusetts General Hospital. He serves as Director of the Metabolism, Obesity and Nutrition Research Center at Weight Center at Massachusetts General Hospital and Director of the subspecialty fellowship program in Obesity Medicine and Nutrition at MGH. Dr. Kaplan serves as Chairman of Scientific Advisory Board at Rhythm Holding Company, LLC, Chairman of the Scientific Advisory Board at Rhythm Pharmaceuticals, Inc. and Chair of Scirntific Advisory Board at Allergen GI Corp. He serves as Director of the NIH-sponsored Small Animal Metabolic Surgery Core Resource, Member of Scientific Advisory Board of Gelesis Holdings, Inc. (formerly known as Gelesis, Inc.) and Director of the Blackburn Obesity Course at Harvard Medical School. He served as an Advisor of PureTech Health plc, Scientific Advisor of Gastroenterology at GI Dynamics, Inc. and Member of Clinical Advisory Board at Zafgen, Inc. Dr. Kaplan was Founding Director of the Weight Center and the Obesity Research Center at Massachusetts General Hospital (MGH) and Scientific Advisor of Gelesis Holdings, Inc. He completed an Internship and Residency in Internal Medicine, a Fellowship in Gastroenterology at the Massachusetts General Hospital and Harvard Medical School and a fellowship in genetics at the Brigham and Women's Hospital. He received his M.D. and Ph.D. in Molecular Biology, both with distinction from the Albert Einstein College of Medicine. Dr. Kaplan graduated with honors from Harvard University.

Positions